Why Medical Marijuana Might Be a Better Investment Than Recreational Pot

Why MedReleaf Corp (TSX:LEAF) might have more upside in the long term than Aurora Cannabis Inc (TSX:ACB).

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Marijuana legalization is set to take place next summer, which could be a great opportunity to lock in a position now before we see pot stocks take off even further. However, one important question that investors should consider is whether to invest in recreational pot stocks or medicinal ones.

Growth potential could vary depending on the segment

Recreational pot is all the hype with stocks like Aphria Inc (TSX:APH) and Aurora Cannabis Inc (TSX:ACB) recently seeing their share prices double. Although growth is expected to be very strong for recreational pot, there are significant challenges that could hinder this growth.

The big assumption is that existing pot users who currently buy weed from the industry’s black market will now simply purchase it from licensed suppliers instead. It’s rather ironic, to say the least, that a pot user will now buy from the very government that once imprisoned many users for possessing and using the drug.

Although the government has now turned the corner and is welcoming pot with open arms, even if the black market disappears and users buy from approved vendors, there could still be unintended consequences of widespread drug use that could be problematic.

For instance, we should consider what impact consumption will have on such things as impaired driving and addiction, and the workplace. These are all serious issues that could make the government think twice.

Investors shouldn’t forget that if the power shifts back to the conservatives in the next federal election, then all bets are off and we could see many more restrictions on marijuana, which could then undermine any potential growth in the industry.

Medical marijuana may have stronger prospects for growth

MedReleaf Corp (TSX:LEAF) focuses on marijuana for medicinal purposes, and although this doesn’t generate as much excitement as recreational pot does, it might present greater opportunities for growth.

The World Health Organization (WHO), recently released a report stating that cannabidiol (CBD), which is the key chemical found in medical marijuana, “exhibits no effects indicative of any abuse or dependence potential.” This is contrast to tetrahydrocannabinol (THC), which is found in pot used for recreational purposes to give users a high.

The WHO also went a step further, stating that “CBD has been demonstrated as an effective treatment of epilepsy in several clinical trials.” The organization is expected to release another report in May, which will provide a more complete review of CBD.

A strong endorsement from the WHO could see medical marijuana stocks take off and lead to wider use of the product, especially from patients seeking effective pain relief without the danger of addiction.

Why this matters to investors

Medical marijuana presents significant potential for growth. Unlike recreational pot, however, it doesn’t possess the same risks that are associated with getting high. Over the long term, medical marijuana could see tremendous growth and generate significant returns for investors.

In the past year, MedReleaf has seen its revenues more than double, and unlike many recreational pot stocks, it has seen its bottom line grow as well. In 2017, the company’s profit of $11 million made up more than 27% of MedReleaf’s top line. This would prove an impressive margin by any standard.

Should you invest $1,000 in Aurora Cannabis right now?

Before you buy stock in Aurora Cannabis, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Aurora Cannabis wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,058.57!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 38 percentage points since 2013*.

See the Top Stocks * Returns as of 2/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any stocks mentioned.

If You Thought Apple and Microsoft Were Big, You Need to Read This.

The steel industry produced the world's first $1 billion company in 1901, and it wasn't until 117 years later that technology giant Apple became the first-ever company to reach a $1 trillion valuation.

But what if I told you artificial intelligence (AI) is about to accelerate the pace of value creation? AI has the potential to produce several trillion-dollar companies in the future, and The Motley Fool is watching one very closely right now.

Don't fumble this potential wealth-building opportunity by navigating it alone. The Motley Fool has a proven track record of picking revolutionary growth stocks early, from Netflix to Amazon, so become a premium member today.

See the 'AI Supercycle' Stock

More on Investing

chart reflected in eyeglass lenses
Dividend Stocks

TFSA $7K: Where to Invest Right Now

TFSA users can invest their $7K annual limits in two profitable large-cap dividend stocks right now.

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Investing

The Best Canadian Stocks to Buy and Hold Forever in a TFSA

For investors looking to add to their TFSA, here are two top Canadian growth stocks that may be worth buying…

Read more »

A close up color image of a small green plant sprouting out of a pile of Canadian dollar coins "loonies."
Investing

2 Brilliant Canadian Stocks to Buy Now and Hold for the Long Term

A small-cap and a large-cap Canadian tech stock can both be terrific holdings to consider for your self-directed investment portfolio,…

Read more »

calculate and analyze stock
Investing

Top Canadian Stocks to Buy Right Now With $7,000

Given their solid underlying businesses, consistent performances, and healthy growth prospects, the following three Canadian stocks are ideal additions to…

Read more »

Paper Canadian currency of various denominations
Dividend Stocks

6% Dividend Yield? Buy This Top-Notch Dividend Stock in Bulk!

This top-notch dividend stock offers a high and sustainable yield of about 6%, enabling you to generate resilient passive income.

Read more »

data analyze research
Dividend Stocks

2 High-Dividend TSX Stocks to Buy for Increasing Payouts

For big dividends with increasing payouts, look more closely at TD and CNQ today!

Read more »

Investor wonders if it's safe to buy stocks now
Dividend Stocks

Better Dividend Stock: TD vs. BCE

TSX dividend stocks such as TD and BCE offer shareholders a tasty dividend yield. But which blue-chip stock is a…

Read more »

Make a choice, path to success, sign
Dividend Stocks

Magna International: Buy, Sell, or Hold in 2025?

Magna International stock: A 5.5% dividend yield and a cheap 8.1 forward P/E – Can the automotive sector stock outrun…

Read more »